Literature DB >> 822941

Cardiotoxicity of adriamycin and related anthracyclines.

L Lenaz, J A Page.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 822941     DOI: 10.1016/s0305-7372(76)80018-7

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  60 in total

Review 1.  Doxorubicin effects on contractile structures and molecules.

Authors:  R Colombo; A Milzani; A Necco; G Vailati
Journal:  Cytotechnology       Date:  1990-01       Impact factor: 2.058

Review 2.  The role of antitumor antibiotics in current oncologic practice.

Authors:  H L Davis; D D von Hoff; J E Henney; M Rozencweig
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

3.  Differences in lipoprotein concentration and composition modify the plasma distribution of free and liposomal annamycin.

Authors:  K M Wasan; R E Morton
Journal:  Pharm Res       Date:  1996-03       Impact factor: 4.200

4.  Fractionated anthracycline therapy in acute myeloblastic leukaemia in adults.

Authors:  S M Donohue; B J Boughton
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

5.  Oxidative and non-oxidative mechanisms in the inactivation of cardiac mitochondrial electron transport chain components by doxorubicin.

Authors:  O Marcillat; Y Zhang; K J Davies
Journal:  Biochem J       Date:  1989-04-01       Impact factor: 3.857

6.  Adriamycin cardiotoxicity: report of an unusual case with features resembling endomyocardial fibrosis.

Authors:  W Fitter; D J deSa; K R Pai
Journal:  J Clin Pathol       Date:  1981-06       Impact factor: 3.411

7.  Ultrastructural features of Adriamycin-induced skeletal and cardiac muscle toxicity.

Authors:  J H Doroshow; C Tallent; J E Schechter
Journal:  Am J Pathol       Date:  1985-02       Impact factor: 4.307

8.  Selectivity of the anthracyclines for negatively charged model membranes: role of the amino group.

Authors:  T G Burke; A C Sartorelli; T R Tritton
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

9.  Elevation of serum lipid peroxide level associated with doxorubicin toxicity and its amelioration by [dl]-alpha-tocopheryl acetate or coenzyme Q10 in mouse (doxorubicin, toxicity, lipid peroxide, tocopherol, coenzyme Q10).

Authors:  N Yamanaka; T Kato; K Nishida; T Fujikawa; M Fukushima; K Ota
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

10.  Detection of adriamycin-induced cardiotoxicity in cultured heart cells with technetium 99m-SESTAMIBI.

Authors:  D Piwnica-Worms; M L Chiu; J F Kronauge
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.